advocacy

Politics By Nicholas Florko and Rachel Cohrs

AbbVie dramatically boosts its spending on lobbying

First Opinion Podcast By Patrick Skerrett

Listen: The faces of Covid at 1 million deaths and counting

D.C. Diagnosis By Nicholas Florko

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

First Opinion By Joe Lieberman and Michelle McMurry-Heath

Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures

First Opinion By Fiona Hathorn

‘Boards for All?’ Global health organizations and companies aren’t even close

Politics By Rachel Cohrs

Manchin won’t support new health policy unless Congress rolls back Trump tax cuts

Politics By Nicholas Florko

Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies

First Opinion Podcast By Patrick Skerrett

Listen: Covid turned the nation’s eyes to nursing homes. Have we already looked away?

D.C. Diagnosis By Nicholas Florko

Biogen’s head-scratching new lobbyist hire

First Opinion By Shikha Jain, Vineet Arora and Eve Bloomgarden

The ‘bot holiday’ and why clinicians can’t tackle disinformation alone

First Opinion Podcast By Patrick Skerrett

Listen: Should gender dysphoria be a required stop en route to gender euphoria?

Business By Tara Bannow

A hospital lobbying juggernaut makes an unlikely pivot into venture capital

First Opinion Podcast By Patrick Skerrett

Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?

First Opinion By Paul Knoepfler

Google’s ongoing stem cell problem points to a larger issue with its search results on unproven therapies

First Opinion By John C. Messinger, Anand Chukka and J. Wesley Boyd

The case for decriminalizing the street sale of buprenorphine

First Opinion By Peter Pronovost

Checklists work well for complicated health care problems. But they don’t work to solve complex ones, like pandemics

First Opinion By Sneha Dave

If pharma can market to youths by TikTok, it should include them in clinical trials

First Opinion By Emma Biegacki

Emergency response systems must not overlook people with substance use disorders

First Opinion Podcast By Patrick Skerrett

Listen: The ‘underground market’ for insulin and diabetes supplies

D.C. Diagnosis By Nicholas Florko

Inside the push for a permanent pandemic preparedness office at the White House

First Opinion By Bill Frist, Jerome M. Adams and Jerold Mande

Commissioner Califf needs to put the F back in FDA

First Opinion By Adam Mossoff

The U.S. must fix its innovation engine: the patent system

First Opinion By Richard J. Baron and Ezekiel J. Emanuel

Politicians should not be deciding what constitutes good medicine

First Opinion By Bret Mettler

Sunsetting medical license reciprocity would return medicine to the dark ages

First Opinion By Bruce Farber and Aradhana Khameraj

Health care workers don unnecessary protective gear. The CDC and WHO need to update their PPE guidance